Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial. (bmj.com)

Authors: Ma F … Xu B Journal: BMJ Published: 2026-03-16 DOI: https://doi.org/10.1136/bmj-2025-087259